Prostate Cancer Prevention

Jack Cuzick, Mangesh A. Thorat

$214.95 $171.85

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Springer-Verlag Berlin and Heidelberg GmbH & Co. K
03 September 2016

Oncology; Urology & urogenital medicine

Series: Recent Results in Cancer Research

Prostate cancer is by far the most common cancer in men and the second leading cause of death due to cancer. It comprises a mixed group of tumours displaying varying clinical behaviour: while some have a very aggressive course, others are rather indolent. Prevention of prostate cancer and discrimination between aggressive and indolent forms are important clinical goals and the acquisition of significant new evidence on means of achieving these aims makes this book particularly timely. A wide range of topics are covered by leading authorities in the field. The biology and natural history of prostate cancer are reviewed and the role of lifestyle and dietary factors, assessed. Detailed attention is paid to risk prediction biomarkers and to the role of novel high-throughput nucleic acid-based technologies in improving risk prediction and thereby allowing tailored approaches to cancer prevention. Potential means of chemoprevention of prostate cancer are also reviewed in depth, covering the very positive new data on the impact of aspirin as well as evidence regarding 5α-reductase inhibitors, DFMO and lycopene. Guidance is provided on the differentiation of aggressive from indolent disease and the policy and research implications of recent findings are examined. This book will be of interest to both clinicians and researchers.

Edited by: Jack Cuzick, Mangesh A. Thorat
Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Country of Publication: Germany
Edition: Softcover reprint of the original 1st ed. 2014
Volume: 202
Dimensions: Height: 235mm, Width: 155mm, Spine: 10mm
Weight: 2.818kg
ISBN: 9783662524435
ISBN 10: 3662524430
Series: Recent Results in Cancer Research
Pages: 169
Publication Date: 03 September 2016
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Biology and natural history of prostate cancer.- Nutrition and prostate cancer.- Prostate cancer chemoprevention.- Lifestyle and dietary factors.- GWAS in prostate cancer predisposition and application to screening and prevention.- Risk prediction biomarkers – CCP.- Risk prediction biomarkers - TMPRSS2-ERG.- Risk prediction biomarkers – PCA3.- Risk adapted chemoprevention for PCa.- Outlook for 5α reductase inhibitors in prostate cancer prevention.- Prostate cancer chemoprevention: Aspirin.- Prostate cancer chemoprevention: DFMO.- Prostate cancer chemoprevention: Lycopene.- Distinguishing aggressive from indolent prostate cancer.- Prognosis and Management of low grade disease - Management of Gleason 6.- Prostate cancer prevention: Policy & Research implications.

Reviews for Prostate Cancer Prevention

From the reviews: Part of the Recent Advances in Cancer Research series, this book's title suggests that it tackles prevention of prostate cancer. ... scientists and clinicians who deal with prostate cancer are the main audience. ... The discussion of agent development and strategies is very useful to anyone looking to tackle the challenging area of prostate cancer chemoprevention. (Leonard G. Gomella, Doody's Book Reviews, May, 2014)